Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.

Gurley BJ, Swain A, Hubbard MA, Hartsfield F, Thaden J, Williams DK, Gentry WB, Tong Y.

Clin Pharmacol Ther. 2008 Jan;83(1):61-9. Epub 2007 May 9.

PMID:
17495878
2.

Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymes.

Zadoyan G, Fuhr U.

Planta Med. 2012 Sep;78(13):1428-57. doi: 10.1055/s-0031-1298536. Epub 2012 May 15. Review.

3.

Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).

Anke J, Ramzan I.

J Ethnopharmacol. 2004 Aug;93(2-3):153-60. Review.

PMID:
15234747
4.

Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance.

Gurley BJ, Fifer EK, Gardner Z.

Planta Med. 2012 Sep;78(13):1490-514. doi: 10.1055/s-0031-1298331. Epub 2012 May 7. Review.

5.

Drugs as CYP3A probes, inducers, and inhibitors.

Liu YT, Hao HP, Liu CX, Wang GJ, Xie HG.

Drug Metab Rev. 2007;39(4):699-721. Review.

PMID:
18058330
6.

Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration.

Ulbricht C, Basch E, Boon H, Ernst E, Hammerness P, Sollars D, Tsourounis C, Woods J, Bent S.

Expert Opin Drug Saf. 2005 Jul;4(4):779-94. Review.

PMID:
16011454
7.

Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

Zhou SF.

Curr Drug Metab. 2008 May;9(4):310-22. Review.

PMID:
18473749
8.

Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

Fasinu PS, Gurley BJ, Walker LA.

Curr Drug Metab. 2015;17(1):52-64. Review.

PMID:
26526838
9.

Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements.

Gurley BJ.

Planta Med. 2012 Sep;78(13):1478-89. doi: 10.1055/s-0031-1298273. Epub 2012 Feb 9. Review.

10.

Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!

Nowack R.

Nephrology (Carlton). 2008 Jun;13(4):337-47. doi: 10.1111/j.1440-1797.2008.00940.x. Epub 2008 Mar 17. Review.

PMID:
18363644
11.

Herb-drug pharmacokinetic interactions reviewed.

Tarirai C, Viljoen AM, Hamman JH.

Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1515-38. doi: 10.1517/17425255.2010.529129. Epub 2010 Nov 11. Review.

PMID:
21067427
12.

Anesthetic considerations of the herbal, kava.

Raduege KM, Kleshinski JF, Ryckman JV, Tetzlaff JE.

J Clin Anesth. 2004 Jun;16(4):305-11. Review.

PMID:
15261327
13.

Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.

Showman AF, Baker JD, Linares C, Naeole CK, Borris R, Johnston E, Konanui J, Turner H.

Fitoterapia. 2015 Jan;100:56-67. doi: 10.1016/j.fitote.2014.11.012. Epub 2014 Nov 22. Review.

PMID:
25464054
14.

Kava Hepatotoxicity: Are we any closer to the truth?

Anke J, Ramzan I.

Planta Med. 2004 Mar;70(3):193-6. Review.

PMID:
15114493
15.

Translational research insights into pharmacokinetic herb-drug interactions.

Hao H, Zheng X, Li P, Wang G.

Curr Drug Metab. 2011 Nov;12(9):850-70. Review.

PMID:
21619523
16.

Analysis of kavalactones from Piper methysticum (kava-kava).

Bilia AR, Scalise L, Bergonzi MC, Vincieri FF.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 5;812(1-2):203-14. Review.

PMID:
15556499
17.

Kava--the unfolding story: report on a work-in-progress.

Denham A, McIntyre M, Whitehouse J.

J Altern Complement Med. 2002 Jun;8(3):237-63. Review.

PMID:
12165183

Supplemental Content

Support Center